<?xml version="1.1" encoding="UTF-8" standalone="yes"?><xml><head><creation_date>D:20080912154119+02'00'</creation_date><modification_date>D:20080912154122+02'00'</modification_date><initial_authorization>False</initial_authorization><pdf_file>EU-1-99-100_h_a_dec_11.pdf</pdf_file></head><body><section><header>en  
   en</header></section><section><header>en</header></section><section><header>en</header><p>1</p></section><section><header>en</header><p>commission of the european communities</p><p>brussels, 02-ix-2008 c(2008)4950 
 not for publication</p></section><section><header>commission decision of 02-ix-2008 
 amending the marketing authorisation for &quot;cetrotide - cetrorelix (as acetate)&quot;, a 
 medicinal product for human use, granted by decision c(1999)939</header><p>(only the english text is authentic)</p></section><section><header>en</header><p>2</p></section><section><header>en</header></section><section><header>commission decision of 02-ix-2008 
 amending the marketing authorisation for &quot;cetrotide - cetrorelix (as acetate)&quot;, a 
 medicinal product for human use, granted by decision c(1999)939 
 (text with eea relevance)</header><p>the commission of the european communities, having regard to the treaty establishing the european community, 
 having regard to regulation (ec) no 726/2004 of the european parliament and of the 
 council of 31 march 2004 laying down community procedures for the authorisation and 
 supervision of medicinal products for human and veterinary use and establishing a 
 european medicines agency
 1, and in particular article 10(2) thereof, having regard to commission regulation (ec) no 1085/2003 of 3 june 2003 concerning 
 the examination of variations to the terms of a marketing authorisation for medicinal 
 products for human use and veterinary medicinal products falling within the scope of 
 council regulation (eec) no 2309/93
 2, and in particular the third subparagraph of article 4(5) thereof, 
 having regard to the notifications submitted by serono europe limited under article 
 4(1) of regulation (ec) no 1085/2003, 
 having regard to directive 2001/83/ec of the european parliament and of the council of 
 6 november 2001 on the community code relating to medicinal products for human use
 3, and in particular article 61(3) thereof, 
 whereas: 
 (1)</p><p>the european medicines agency acknowledged, between 18 january 2008 and 
 18 july 2008, the validity of the notification(s) for minor variations of type ia, 
 informing the marketing authorisation holder accordingly, and has prepared a list 
 of the notification(s). the variation(s) took effect from the date of the 
 communication from the european medicines agency concerning the validation.</p><p>
 1 oj l 136, 30.4.2004, p. 1, regulation as last amended by regulation (ec) no 1394/2007 (oj l 324, 10.12.2007, p. 121). 
 2 oj l 159, 27.6.2003, p. 24. 3 oj l 311, 28.11.2001, p. 67, directive as last amended by directive 2008/29/ec (oj l 81, 20.3.2008, p.51).</p></section><section><header>en</header><p>3</p></section><section><header>en</header><p>(2) serono europe limited submitted, under article 61(3) of directive 2001/83/ec, a 
 notification(s) for changes to an aspect of the labelling or the package leaflet, 
 which has (have) not yet been included in decision c(1999)939 of 13 april 1999. 
 (3)</p><p>the marketing authorisation should be updated, and decision c(1999)939 of 13 
 april 1999 amended accordingly. 
 (4)</p><p>for the sake of clarity and transparency, it is advisable, following the amendment 
 of part or parts of the annexes, to provide for a consolidated version thereof. the 
 annexes to decision c(1999)939 should therefore be replaced, 
 has adopted this decision: 
 article 1 decision c(1999)939 is amended as follows: 1) the following list of notifications for minor variations is added to the updated 
 marketing authorisation. 
 application number 
 scope (eu numbers affected) 
 emea/h/c/233/ia/0024 
 8.b.1 (ia) (eu/1/99/100/001-003)</p><p>
 2) the following list of notifications for changes to an aspect of the labelling or the 
 package leaflet is added to the updated marketing authorisation; 
 application number 
 annex (eu numbers affected) 
 emea/h/c/233/n/0022 
 iiib (eu/1/99/100/001-003)</p><p>
 3) annex ii is replaced by the text set out in annex ii to this decision; 
 4) annex iii b is replaced by the text set out in annex iii b to this decision.</p></section><section><header>en</header><p>4</p></section><section><header>en</header><p>article 2 this decision is addressed to serono europe limited, 56, marsh wall, london e14 9tp, united kingdom. 
 done at brussels, 02-ix-2008 
 for the commission heinz zourek 
 director-general</p></section></body></xml>